| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| July 1, 2026 | ±3.0% | -1.6% | over-priced |
| January 8, 2026 | ±2.6% | +5.3% | under-priced |
| October 7, 2025 | ±2.3% | +1.0% | over-priced |
| July 2, 2025 | ±2.1% | +4.5% | under-priced |
| January 10, 2025 | ±2.4% | -17.1% | under-priced |
| October 3, 2024 | ±1.5% | -4.7% | under-priced |
| July 3, 2024 | ±1.7% | -3.3% | under-priced |
| January 5, 2024 | ±1.1% | +2.1% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2027 | — | $2.4B | $672M |
| Q4 FY2026 | — | $1.9B | $202M |
| Q3 FY2026 | — | $2.2B | $522M |
| Q2 FY2026 | — | $2.5B | $486M |
Constellation Brands, Inc. (STZ) reports in 107 days, with the next report estimated for November 12, 2026. Across the last 8 reports, options priced an average ±2.1% earnings move while the stock actually moved 5.0% on average — the market has tended to under-price STZ's earnings risk. Fundamentals into the print: EPS up 0.0% year-over-year, revenue down 3.3%. QuantLogix's live 5-factor engine currently reads STZ as a sell at 38/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →